Skip to main content
. 2024 Oct 2;15:1470148. doi: 10.3389/fphar.2024.1470148

FIGURE 1.

FIGURE 1

Outcomes for serious adverse events associated with DNA Methylation Inhibitors at the level of preferred terms (major events comprising life-threatening events, disability, and congenital anomaly).